Rachael

AVBCC Value-Based Voices

Business EN ↓ 19 episodes

The Association for Value-Based Cancer Care’s (AVBCC) podcast series addresses the ever-evolving landscape of value related to cancer care in the United States. Our goal is to foster informed dialogue, promote transparency, and empower all players to navigate the rapidly changing landscape of cancer care with clarity and confidence.

Be sure to visit the podcast's website and support the creator: www.buzzsprout.com

Author

Rachael

Category

Business

Podcast website

www.buzzsprout.com

Latest episode

Nov 12, 2026

Where to listen?

Podcasts in the app Replaio Radio Coming soon

Podcasts are coming to the app soon. Install now and be the first to see a whole new take on podcasts

Get it on Google Play Install for free Android 10M+ downloads · 4.7+ rating iOS soon

Episodes

Ted Slafsky on 340B's Triple Threat: CMS Cuts, the Rebate Model Fight & Contract Pharmacy in Court 12.11.2026

CMS has just finalized a cut to hospital payments for 340B drugs, from ASP+6% down to ASP-28%. The lawsuits are already on the way. Host Jayson Slotnik sits down with Ted Slafsky, Publisher and CEO of the 340B Report, to break down three fast-moving 340B fights: the new CMS reimbursement decision, the hospital lawsuit against HRSA's 340B rebate model (oral arguments November 18 in Portland, M...

Medicare Advantage, AI, MFN, China, and Consensus Building: Powerful Insights from HLC 15.10.2026

Value-Based Voices welcomes Maria Ghazal, JD, MA, President & CEO, Healthcare Leadership Council, for a dynamic conversation spanning Medicare Advantage, prior authorization reform, artificial intelligence, Most Favored Nation drug pricing, and the growing competitive pressure from China in biopharmaceutical innovation. During this conversation, hosted by Jayson Slotnik, JD, MPH, Partner at He...

Who Gets Access? Understanding the New Reality of Cancer Drug Coverage 29.09.2026

Are oncology treatments losing their "special status" with payers? In this episode of Value-Based Voices, host Brian Reid, MS , Principal of Reid Strategic and author of the Cost Curve newsletter, sits down with James Chambers, PhD, MSc, MPharm , Professor at Tufts University School of Medicine and Director of the Specialty Drug Evidence and Coverage (SPEC) Database , to examine how paye...

AI at the Point of Care: Inside OpenEvidence's Approach to Smarter Clinical Decisions 25.09.2026

Artificial intelligence is rapidly reshaping healthcare, but what does that look like in the day-to-day practice of oncology? In this episode of AVBCC's Value-Based Voices, host Jayson Slotnik, JD, MPH , Partner at Health Policy Strategies, and AVBCC Board Member, sits down with Samyukta Mullangi, MD, MBA , Medical Oncologist at Tennessee Oncology and Vice President of Clinical Strategy at Op...

From Patient to Person: Redefining Cancer Care at the AVBCC LA Regional Collaborative 01.09.2026

In this episode of Value‑Based Voices, host Deirdre “Dee” Saulet, PhD, Chief Strategy Officer, Jasper Health, and AVBCC Southwest Regional Collaborative Co-Chair, sits down with two extraordinary guests, Kommah "Koko" McDowell, MS, a 21‑year survivor, nationally recognized advocate, and Chief Customer Officer at Tali Health, and Leon Cristobal, MPH, an eight‑year leukemia survivor, and O...

Red Tape: Real Consequences for Patients with Cancer 25.08.2026

What happens when patients with cancer spend weeks navigating insurance requirements before receiving physician-prescribed care? In our latest episode of Value-Based Voices, Brian Reid , Principal of Reid Strategic and author of the Cost Curve newsletter, and Jayson Slotnik , JD, MPH, Partner at Health Policy Strategies, and AVBCC Board Member, sit down with Cancer Care' s  Alexandra Zaleta ,...

Part D Upheaval: Why the Cancer Community Needs to Pay Attention 11.08.2026

In this episode of Value-Based Voices, host Jayson Slotnik, JD, MPH, Partner at Health Policy Strategies, and AVBCC Board Member, sits down with Joel White, Partner and Head of Health Practice at Monument Advocacy, and a principal architect of Medicare Part D, to discuss one of the most consequential challenges facing cancer care today: the end of the Part D Premium Stabilization Demonstration.  B...

Can the U.S. Keep Its Edge? FDA Policy, China’s Momentum, and the Future of Innovation 04.08.2026

In this follow up conversation, Jayson Slotnik, JD, MPH , Partner at Health Policy Strategies and AVBCC Board Members, and Steve Usdin , Senior Editor, Washington, BioCentury Publications, take a clear eyed look at the future of the FDA and the forces shaping biopharmaceutical innovation. Building on their earlier discussion of FDA history and political dynamics, Steve offers candid insights into...

The Future of the FDA: What Comes Next? 28.07.2026

In this first of a 2-part series featuring Steve Usdin , Senior Editor, Washington, BioCentury Publications, host Jayson Slotnik, JD, MPH , Partner at Health Policy Strategies and AVBCC Board Member, leads a spirited conversation around  developments at the FDA, the political influence shaping its decisions, and the outlook for the future.  Key topics covered include: The state of morale among FDA...

Reflections on the NCCN 30.06.2026

In this episode of Value-Based Voices, we delve into the mission and inner workings of the NCCN, a cornerstone organization shaping cancer treatment standards in the U.S. and beyond. We're joined by Bill McGivney, PhD , Principal, McGivney Global Advisors, and Former CEO, NCCN; and host Nicolas Ferreyros , Managing Director, Policy, Advocacy, and Communications, Community Oncology Alliance. ...

Advancing Cancer Research and Innovation through Collaboration at GCRIS 2026 16.06.2026

We're taking a deep dive into the upcoming Global Cancer Research and Innovation Symposium (GCRIS) in this latest episode of Value-Based Voices. Join GCRIS Scientific Co-chairs Stan Skrzypczak, MS, MBA , Managing Partner, 5 Prime Life Science Consulting, and Nick Sarlis, MD, PhD, FACP , Chief Medical Officer, Cleara Biotech, as they talk with GCRIS Co-chair Matt Vossler , Managing Director, D...

Breaking the Model: Can Value-Based Insurance Deliver? 02.06.2026

Most cancer drugs today are more effective and accessible than ever—yet patients often face crushing costs because our healthcare system still values profit over patient benefit. What if the key to transforming cancer care affordability lies in rethinking insurance design, reforming PBMs, and empowering employers with transparent data?  In this eye-opening episode of Value-Based Voices, host Jayso...

From the Human Genome Project to 48 Hours: The Rapid Evolution of Tumor Biology 19.05.2026

Most treatments and diagnostics once took years and hundreds of millions of dollars. Today, it costs less than $100,000 to sequence a genome and open the door to tailored cancer therapies that could save lives. But understanding tumor biology is only half the battle. The real challenge lies in interpreting complex genetic data quickly, accurately, and at scale. In this episode of AVBCC’s Value-Bas...

Navigating Value and Policy in U.S. Cancer Care and Pharma Pricing 30.04.2026

International reference pricing could drastically reshape drug costs in the U.S. and threaten domestic innovation. In this latest episode of AVBCC’s Value-Based Voices, join Jayson Slotnik, JD, MPH, Partner, Health Policy Strategies, Inc., and Member of the AVBCC Board of Directors, and healthcare policy strategist Brian Reid, MS, Founder of Reid Strategic, as they unpack the complex debate over t...

Most Favored Nation and What's Next 14.04.2026

Most companies, and even policymakers, are betting big on importing international drug prices — but what does that really mean for cancer care in America?  In this episode of Value-Based Voices , Jayson Slotnik, JD, MPH,  Partner, Health Policy Strategies, Inc., dives into the evolving landscape of drug pricing reforms, unlocking why policies like the Most Favored Nation (MFN) and the Global Bench...

AI Revolution: Breaking Pharmacy Chains with Harry Travis, BS Pharm, MBA, and Ira Klein, MD, MBA, FACP 17.03.2026

There are countless opportunities hidden in the data-driven tasks pharmacists do every day, and AI is ready to unlock them. But what happens when automation dramatically increases productivity in pharmacy, and how do regulations, workforce, and patient care evolve in tandem? In this latest episode of AVBCC's Value-Based Voices, join Ira Klein , MD, MBA, FACP, VP Medical Affairs, Payer Relatio...

Consolidation Versus Independence in Cancer Care 24.02.2026

Is consolidation in cancer care truly the best path forward, or does independence offer greater benefits? In this episode of Value-Based Voices Sarah Alwardt , PhD, President, Avalere Health, and Jeff Patton, MD , CEO, OneOncology, discuss the nuances of consolidation versus independence in cancer care, the impact of policy and capital access, and the future of value-based oncology. Gain insights...

Insights from JP Morgan 2026 with Liz Fowler, PhD, JD 08.02.2026

Commercial health plans may have been missing from J.P. Morgan 2026, but government had a big presence! Value-Based Voices host Burt Zweigenhaft, PhD, and nationally recognized health policy expert Liz Fowler, PhD, JD, share their observations from this year’s meeting and key insights around most-favored nation prescription drug pricing, 340B, PBMs, Medicare site neutrality, AI, and of course valu...

More Insights from JP Morgan 2026 with Jeff Berkowitz, JD 08.02.2026

Where was the drama at JP Morgan this year? Host Burt Zweigenhaft, PhD, and seasoned healthcare executive Jeff Berkowitz, JD, debate why the 2026 meeting seemed to be missing its normal electricity. They also share their thoughts around challenges with direct-to-patient models, most-favored-nation and its impact on product launch and pricing both in the US and Europe, and how AI may or may not be...

Listen to the AVBCC Value-Based Voices podcast in Replaio

Radio and podcasts in one app - free, with no sign-up. Install today and do not miss the launch

Get it on Google Play

Replaio is not a podcast publisher; show names, artwork and audio belong to their authors and are distributed through public RSS feeds.